Vipul Organics Secures BSE Nod for Rs 35.2 Crore Preferential Issue, Boosting Growth Prospects

2 min read     Updated on 09 Dec 2025, 01:30 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Vipul Organics Limited has received in-principle approval from BSE for a preferential issue of 16,70,000 equity shares to non-promoters at Rs 211 per share, potentially raising Rs 35.2 crore. The issue price represents a premium over the current market price. The company must comply with regulatory requirements and obtain separate listing approval after allotment. This capital infusion could significantly impact the company's financial structure, potentially increasing share capital by 12.78% and total equity by 54.83%.

26812852

*this image is generated using AI for illustrative purposes only.

Vipul Organics Limited , a key player in the chemical industry, has received a significant boost to its growth plans. The company announced that it has secured in-principle approval from the Bombay Stock Exchange (BSE) for a preferential issue of equity shares to non-promoters, potentially raising Rs 35.2 crore.

Preferential Issue Details

The BSE approval, granted on December 8, allows Vipul Organics to issue 16,70,000 equity shares with a face value of Rs 10 each. The shares will be offered at a price of Rs 211 per share, representing a substantial premium to the current market price. This move is expected to strengthen the company's financial position and provide capital for future growth initiatives.

Particular Details
Number of Shares 16,70,000
Face Value Rs 10
Issue Price Rs 211
Total Fund Raise Rs 35.2 crore
Allotment Type Preferential Issue
Allottees Non-promoters

Regulatory Compliance and Next Steps

While the in-principle approval is a positive development, Vipul Organics must still navigate several regulatory requirements:

  1. The company needs to ensure strict compliance with the Companies Act, 2013, Securities Contracts (Regulation) Act, 1956, and other relevant regulations.
  2. Separate listing approval must be obtained after the allotment of shares.
  3. The company is required to file a listing application within 20 days of the allotment date.

Financial Implications

The preferential issue, if fully subscribed, could significantly impact Vipul Organics' financial structure. Based on the latest available balance sheet data:

Financial Metric Pre-Issue (Rs crore) Potential Post-Issue (Rs crore)* % Change
Share Capital 13.30 15.00 12.78%
Shareholders' Capital 64.20 99.40 54.83%
Total Equity 64.20 99.40 54.83%

*Estimated figures assuming full subscription of the preferential issue

This capital infusion could potentially strengthen the company's balance sheet, providing additional resources for expansion, debt reduction, or working capital needs.

Market Implications

The preferential issue at Rs 211 per share, significantly above the face value of Rs 10, suggests confidence in the company's future prospects. This premium pricing could be viewed positively by the market, potentially influencing investor sentiment and the stock's performance in the near term.

Investors and market participants will be keenly watching how Vipul Organics utilizes this additional capital to drive growth and enhance shareholder value. The company's ability to effectively deploy these funds will be crucial in justifying the premium valuation of the preferential issue.

Historical Stock Returns for Vipul Organics

1 Day5 Days1 Month6 Months1 Year5 Years
+0.51%+1.62%+17.39%+22.83%+4.73%+222.39%
Vipul Organics
View in Depthredirect
like16
dislike

Vipul Organics Expands Pigment Capacity and Ventures into Membrane Manufacturing

1 min read     Updated on 01 Dec 2025, 03:51 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Vipul Organics Limited plans to expand its pigment production capacity from 2,000 to 10,000 tonnes annually with a new Greenfield facility in Sayakha, Gujarat. The company is also diversifying into membrane manufacturing technology, leveraging expertise from Dr. Vatsal Shah. Financial performance shows growth with revenue increasing by 8.01% to ₹163.10 cr and net profit rising by 33.33% to ₹4.40 cr in FY 2024-25 compared to the previous year. The new plant is expected to commence operations in about 12 weeks, potentially improving EBITDA and competitiveness against international players.

26130095

*this image is generated using AI for illustrative purposes only.

Vipul Organics Limited , a key player in the Indian pigment industry, is set to expand its production capacity and diversify into membrane manufacturing technology. This strategic move aims to strengthen the company's position in the domestic and global markets.

Expansion of Pigment Production

Vipul Organics plans to commission a new Greenfield facility in Sayakha, Gujarat, which is expected to increase its pigment production capacity. The company aims to scale up from its current 2,000 tonnes per year to nearly 10,000 tonnes annually. This five-fold increase in capacity is anticipated to enhance the company's competitiveness, particularly against Chinese manufacturers.

Diversification into Membrane Manufacturing

In a move to diversify its product portfolio, Vipul Organics is venturing into membrane manufacturing technology. This decision leverages the expertise of Dr. Vatsal Shah, who recently completed his Ph.D. in membrane technology from Imperial College London. The company aims to address a gap in the Indian market, which currently relies heavily on imported membranes from the US, Korea, and China.

Financial Performance

Vipul Organics has shown growth in recent years. Here's a look at the company's key financial metrics:

Financial Metric FY 2024-25 FY 2023-24 YoY Change
Revenue ₹163.10 cr ₹151.00 cr 8.01%
EBITDA ₹14.90 cr ₹12.60 cr 18.25%
Net Profit ₹4.40 cr ₹3.30 cr 33.33%
EPS ₹2.70 ₹2.09 29.19%

The company has demonstrated growth across key financial parameters, with improvements in profitability metrics.

Future Outlook

With the new Sayakha plant expected to commence operations in approximately 12 weeks, Vipul Organics anticipates an improvement in its EBITDA. The increased production capacity is expected to reduce costs and enhance the company's ability to compete with international players, particularly those from China.

The entry into membrane manufacturing represents a strategic diversification that could open up new revenue streams for the company. By offering membranes at competitive prices, Vipul Organics aims to capture a share of the growing domestic market for these products.

As Vipul Organics continues to expand its production capacity and diversify its product range, it is positioning itself in both the pigment industry and the emerging field of membrane technology in India. The coming months will be crucial as the company operationalizes its new facility and establishes its presence in the membrane market.

Historical Stock Returns for Vipul Organics

1 Day5 Days1 Month6 Months1 Year5 Years
+0.51%+1.62%+17.39%+22.83%+4.73%+222.39%
Vipul Organics
View in Depthredirect
like16
dislike
More News on Vipul Organics
Explore Other Articles
216.00
+1.10
(+0.51%)